Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Supplementation with ESA for Chemotherapy-Induced Anemia
NCT00482716Phase 3Unknown
- Sponsor
- St Bartholomew's Hospital
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of iron sucrose and iron dextran (2 arms), sponsored by St Bartholomew's Hospital. Primary endpoint: Maximum hemoglobin achieved. Status: unknown.
02
Drugs
iron sucroseiron dextran
Beyond the preview
Go deeper on NCT00482716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482716.